Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate for Bone Health in Postmenopausal Women with DCIS on Anastrozole
NCT00324714Phase 3Withdrawn
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteoporosis, osteopenia, sponsored by ETOP IBCSG Partners Foundation. Planned start Feb 2003; status: withdrawn.
02
Drugs
risedronate
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00324714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324714.